Source link : https://www.newshealth.biz/health-news/aggressive-infliximab-dosing-shows-no-added-benefit-in-uc/
TOPLINE: Aggressive infliximab dosing regimens – intensified induction or accelerated induction – show similar clinical responses and remission rates as the standard infliximab dosing approach in patients with acute severe ulcerative colitis (ASUC) that is steroid refractory. METHODOLOGY: Infliximab is a commonly used rescue therapy in patients with ASUC; however, its optimal dosing strategy in […]
Author : News Health
Publish date : 2024-11-19 10:32:49
Copyright for syndicated content belongs to the linked Source.
inHealth